nation patent develop corp and bar ilan univers israel said joint ventur corpor scientif test inc will clinic trial it immuno augment compound as101 for treatment acquir immun defici syndrom aid studi will conduct institut immunolog disord anderson hospit houston tex under direct peter mensel pursuant investig new drug applic file with food and drug administr compani said studi expect four six week design test effect as101 about aid patient nation patent said ad as101 proprietari synthet compound invent bar ilan univers doctor has immuno augment anti viral and anti tumor activ preclin anim test and immuno augment activ limit number aid patient phase foreign clinic test reuter 